Cerulean Pharma Inc. develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. It has a collaboration with Novartis Institutes for BioMedical Research, Inc. to develop nanoparticle-drug conjugates. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
